1 / 18

R3 김대언

Advances in the Clinical Pharmacology of Intravenous Anesthetics : Pharmacokinetic, Pharmacodynamic, Pharmaceutical, and Technological Considerations. R3 김대언. Total intravenous anesthesia now an appealing, workable alternative to the inhalational anesthesia .

doria
Download Presentation

R3 김대언

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Advances in the Clinical Pharmacology of Intravenous Anesthetics : Pharmacokinetic, Pharmacodynamic, Pharmaceutical, and Technological Considerations R3 김대언

  2. Total intravenous anesthesia • now an appealing, workable alternative to the inhalational anesthesia

  3. The "surfing" analogy in anesthesia drug selection and administration • anesthesia and reanimation • necessitate a standard of precision and accuracy in drug administration • anesthesiologist • target drug level within a narrow therapeutic window • adequate anesthesia vs rapid emergence

  4. a "surfing" analogy • surfer riding near the crest of wave • target concentration that produce considerable drug effects and recover quickly drug administration is terminated • large reduction in effects with small decrease in concentration

  5. Three approaches • the pharmacodynamic approach • feedback mechanism(propofol titration to EEG and muscle relaxant) • the pharmacokinetic approach • TCI • the pharmaceutical approach • unnecessary to hit the target with as much precisions and accuracy as with the other approaches

  6. Pharmacokinetic considerations • pharmacologic modeling • fitting mathematical equations to raw pharmacologic data • a set of parameters that describe in quantitative terms a drug's disposition and effect in the body • pharmacokinetic parameters : clearance, distribution volumes, half life • "what the body does to the drug" • pharmacodynamic parameters : potency • "what the drug does to the body"

  7. The goal of PK-PD modeling • provide the practitioner with the knowledge necessary to formulate rational dosing scheme • accurately predicting the time course and magnitude of drug effect in any type of patients • to move dose-response analysis

  8. pharmacokinetic component : relationship between the drug dose and the time course of drug concentrations in the body • pharmacodynamic component : relationship between the drug concentration in the site of action and the drug effect • prediction regarding latency to peak effect, magnitude of effect, duration of effect

  9. Context sensitive half-times : a new pharmacokinetic concept • context sensitive half-times : a new pharmacokinetic concept • context : the duration of the continuous infusion • CSHT : 50% decrement time • alfentanil vs sufentanil vs fentanyl

  10. Pharmacodynamic considerations • importance of pharmacodynamic drug interactions and synergy • pharmacodynamic drug interaction : frequently produced by design • modern day anesthesia : at least a two-drug process consisting of an analgesic and a hypnotic agent • anesthesiology is the practice of pharmacologic synergism using CNS depressants

  11. propofol-opioid interaction : characterized using EC50 reduction study methodology • opioid-propofol : relation is highly nonlinear • the dosage reduction of one drug produced by an increase in the other is not simply proportional • the substantial pharmacodynamic synergy of the drug combination • isobolographic drug interaction analysis : rational selection of concentration target pairs for propofol and opioid

  12. revolutionary advance in our understanding of IV anesthetic clinical behavior • propofol : 3.5ug/ml as loss of consciousness in 50% pts 10-15ug/ml to supress to surgical stimuli 1ug/ml in the presence of opioid adjuvant • by using propofol-opioid ratio : applicable to any anesthetic case • function of opioid pharmacokinetics : play a large part of selection of ratio • long acting fentanyl congeners : low opioid and high propofol • short acting opioid : low propofol

  13. play in selecting the appropriate propofol-opioid ratio • hemodynamically compromised pt VS pt prone to nausea and vomiting • isobologram is only a single "slice" through a much larger drug ineraction "surface" • response surface : tool to visualize the nature of the synergy of two drug class

  14. Pharmaceutical considerations • remifentanil : a prototype designer drug • by designing molecules with specialized structure-activity relationship • lose its u-receptor agonist activity on ester hydrolysis • very-short-acting pharmacokinetic activity

  15. can be titrated up and down as necessary to meet the dynamic needs of the patient during rapid changing conditions of anesthesia and surgery • when rapid recovery is desirable • when the anesthetic requirement rapidly fluctuates • when opioid titration is unpredictable or difficult • when there is a substantial danger to opioid overdose • when "high-dose" opioid technique is advantageous but not going to be mechanically ventilated

  16. importance of formulation : propofol as an example • the formulation of a drug can have an important influence on the drug's clinical behavior • propofol : lipid emulsion formulation pain on injection serious allergic reactions inadvertent contamination • prodrug non-lipid excipient lipid-based emulsion • may alter pharmacokinetic and pharmacodynamic characteristic

  17. Technical advances calculating pump • simply specifies a delivery rate as mg/hr or ug/kg/mim • do not achieve the pharmacokinetic exactness • patient-controlled analgesia machine

  18. computer-controlled infusion pump • by coding a pharmacokinetic model into a computer program and linking it into an electric pump • design target concentration and calculate the necessary infusion rate by TCI system • gradually decrease the rate of infusion based on the pharmacokinetics • change the infusion rate frequently • require knowledge of the therapeutic concentration for clinical application

More Related